Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Washington University School of Medicine
Age
21–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
21 years of age or older
Newly diagnosed with stage I-III breast cancer
Scheduled to receive 21-day cycles of intravenous chemotherapy
Experiencing disrupted sleep (determined by Pittsburgh Sleep Quality Index)
Morning or evening types (determined by Horne-Ostberg Morningness-Eveningness Questionnaire (MEQ)
Sighted
Mentally competent to consent
Able to under English
You may not be if
Concurrent malignancy
Undergoing other cancer treatments
Engage in shift work or travel across more than 3 time zones within 2 weeks prior to study
Known history of seasonal affective disorder or substance abuse
Current diagnosis of major Axis I psychiatric disorders, neurological impairments, or muscular dystrophies
Regularly use steroid or other immunosuppressive medications
Take prescribed sedative hypnotics or sleep medications because these conditions may affect fatigue and/or sleep/wake patterns.
Have eye conditions (glaucoma or retinal disease), problems triggered by bright light (e.g. migraine), or take photosensitizing medications (e.g. some porphyrin drugs, antipsychotics, antiarrhythmic agents)
Clareo Health | Bright Light on Fatigue in Women Being Treated for Breast Cancer
